β-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy

Epilepsy Research

Volumn 117, Issue , 2015, Pages 125-132

  Yum, Mi Sun ^a   Lee, Minyoung ^a   Woo, Dong Cheol ^a   Kim, Dong Wook ^b   Ko, Tae Sung ^a   Velíšek, Libor ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Animal model; Infantile spasms; Ketogenic diet; Ketone body; Hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; ALANINE; ASPARTIC ACID; BETAMETHASONE; CREATINE; CREATINE PHOSPHATE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; PHOSPHORYLCHOLINE; TAURINE; ANTICONVULSIVE AGENT; N METHYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEAR; GESTATION PERIOD; IN VIVO STUDY; INFANTILE SPASM; LATENT PERIOD; LOCOMOTION; MEMORY CONSOLIDATION; NERVE CELL; NONHUMAN; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HUMAN; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; SEIZURES; SPASMS, INFANTILE;

3-HYDROXYBUTYRIC ACID; ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; N-METHYLASPARTATE; RATS; SEIZURES; SPASMS, INFANTILE; TREATMENT OUTCOME;

EID: 84946209007     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2015.08.005     Document Type: Article

References (40)

1. Baram T.Z., Mitchell W.G., Tournay A., Snead O.C., Hanson R.A., Horton E.J. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996, 97:375-379.
2. Chachua T., Yum M.S., Veliskova J., Velisek L. Validation of the rat model of cryptogenic infantile spasms. Epilepsia 2011, 52:1666-1677.
3. Chmiel-Perzynska I., Kloc R., Perzynski A., Rudzki S., Urbanska E.M. Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro. Neurotox. Res. 2011, 20:40-50.
4. Chowdhury G.M., Jiang L., Rothman D.L., Behar K.L. The contribution of ketone bodies to basal and activity-dependent neuronal oxidation in vivo. J. Cereb. Blood Flow Metab. 2014, 34:1233-1242.
5. Clarke K., Tchabanenko K., Pawlosky R., Carter E., Todd King M., Musa-Veloso K., Ho M., Roberts A., Robertson J., VanItallie T.B., Veech R.L. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 2012, 63:401-408.
6. Davidson T.L., Hargrave S.L., Swithers S.E., Sample C.H., Fu X., Kinzig K.P., Zheng W. Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience 2013, 253:110-122.
7. Dressler A., Stocklin B., Reithofer E., Benninger F., Freilinger M., Hauser E., Reiter-Fink E., Seidl R., Trimmel-Schwahofer P., Feucht M. Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy-the Austrian experience. Seizure 2010, 19:404-408.
8. Eagles D.A. Design of dietary treatment: humans versus rodents. Epilepsia 2008, 49(Suppl. 8):61-63.
9. Ennis K., Dotterman H., Stein A., Rao R. Hyperglycemia accentuates and ketonemia attenuates hypoglycemia-induced neuronal injury in the developing rat brain. Pediatr. Res. 2015, 77:84-90.
10. Eun S.H., Kang H.C., Kim D.W., Kim H.D. Ketogenic diet for treatment of infantile spasms. Brain Dev. 2006, 28:566-571.
11. Goosens K.A., Maren S. Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats. Learn. Mem. 2001, 8:148-155.
12. Hallböök T., Ji S., Maudsley S., Martin B. The effects of the ketogenic diet on behavior and cognition. Epilepsy Res. 2012, 100:304-309.
13. Hashim S.A., VanItallie T.B. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J. Lipid Res. 2014, 55:1818-1826.
14. Kim K.C., Kim P., Go H.S., Choi C.S., Yang S.I., Cheong J.H., Shin C.Y., Ko K.H. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett. 2011, 201:137-142.
15. Kossoff E.H., Hedderick E.F., Turner Z., Freeman J.M. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008, 49:1504-1509.
16. Kossoff E.H., Zupec-Kania B.A., Rho J.M. Ketogenic diets: an update for child neurologists. J. Child Neurol. 2009, 24:979-988.
17. Lambrechts D.A.J.E., Bovens M.J.M., de la Parra N.M., Hendriksen J.G.M., Aldenkamp A.P., Majoie M.J.M. Ketogenic diet effects on cognition, mood, and psychosocial adjustment in children. Acta Neurol. Scand. 2013, 127:103-108.
18. Lund T.M., Obel L.F., Risa Ø., Sonnewald U. β-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons. Neurochem. Int. 2011, 59:309-318.
19. Nehlig A. Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:265-275.
20. Nylen K., Likhodii S., Burnham W.M. The ketogenic diet: proposed mechanisms of action. Neurotherapeutics 2009, 6:402-405.
21. Oz G., Alger J.R., Barker P.B., Bartha R., Bizzi A., Boesch C., Bolan P.J., Brindle K.M., Cudalbu C., Dincer A., Dydak U., Emir U.E., Frahm J., Gonzalez R.G., Gruber S., Gruetter R., Gupta R.K., Heerschap A., Henning A., Hetherington H.P., Howe F.A., Huppi P.S., Hurd R.E., Kantarci K., Klomp D.W., Kreis R., Kruiskamp M.J., Leach M.O., Lin A.P., Luijten P.R., Marja?ska M., Maudsley A.A., Meyerhoff D.J., Mountford C.E., Nelson S.J., Pamir M.N., Pan J.W., Peet A.C., Poptani H., Posse S., Pouwels P.J., Ratai E.M., Ross B.D., Scheenen T.W., Schuster C., Smith I.C., Soher B.J., Tka? I., Vigneron D.B., Kauppinen R.A. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014, 270:658-679.
22. Pan J.W., de Graaf R.A., Petersen K.F., Shulman G.I., Hetherington H.P., Rothman D.L. [2,4-13 C2]-Beta-hydroxybutyrate metabolism in human brain. J. Cereb. Blood Flow Metab. 2002, 22:890-898.
23. Paoli A., Bosco G., Camporesi E.M., Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Front. Psychol. 2015, 6:27.
24. Pellock J.M., Hrachovy R., Shinnar S., Baram T.Z., Bettis D., Dlugos D.J., Gaillard W.D., Gibson P.A., Holmes G.L., Nordl D.R., O'Dell C., Shields W.D., Trevathan E., Wheless J.W. Infantile spasms: a U.S. consensus report. Epilepsia 2010, 51:2175-2189.
25. Plecko B., Stoeckler-Ipsiroglu S., Schober E., Harrer G., Mlynarik V., Gruber S., Moser E., Moeslinger D., Silgoner H., Ipsiroglu O. Oral [bgr]-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of [bgr]-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr. Res. 2002, 52:301-306.
26. Pulsifer M.B., Gordon J.M., Brandt J., Vining E.P., Freeman J.M. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev. Med. Child Neurol. 2001, 43:301-306.
27. Rho J.M., Sankar R. The ketogenic diet in a pill: is this possible?. Epilepsia 2008, 49(suppl. 8):127-133.
28. Riikonen R. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs 2014, 28:279-290.
29. Shin C.G., Kim D.W. Effect of β-hydroxybutyrate on flurothyl-induced seizure susceptibility. J. Korean Child Neurol. Soc. 2010, 18:225-229.
30. Singh R.K., Joshi S.M., Potter D.M., Leber S.M., Carlson M.D., Shellhaas R.A. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014, 134:e1431-e1435.
31. Snoussi K., Gillen J.S., Horska A., Puts N.A.J., Pradhan S., Edden R.A.E., Barker P.B. Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla. Magn. Reson. Med. 2014, (Eub 2014 Sep 22). 10.1002/mrm.25468.
32. Suzuki Y., Takahashi H., Fukuda M., Hino H., Kobayashi K., Tanaka J., Ishii E. Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 2009, 1268:17-23.
33. Tanner G.R., Lutas A., Martinez-Francois J.R., Yellen G. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 2011, 31:8689-8696.
34. Velisek L. Prenatal exposure to betamethasone decreases anxiety in developing rats: hippocampal neuropeptide y as a target molecule. Neuropsychopharmacology 2006, 31:2140-2149.
35. Velisek L., Chachua T., Yum M.S., Poon K.L., Veliskova J. Model of cryptogenic infantile spasms after prenatal corticosteroid priming. Epilepsia 2010, 51(suppl. 3):145-149.
36. Velisek L., Jehle K., Asche S., Veliskova J. Model of infantile spasms induced by N-methyl-d-aspartic acid in prenatally impaired brain. Ann. Neurol. 2007, 61:109-119.
37. Yudkoff M., Daikhin Y., Horyn O., Nissim I., Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 2008, 49:73-75.
38. Yum M.S., Ko T.S., Kim D.W. Anticonvulsant effects of β-hydroxybutyrate in mice. J. Epilepsy Res. 2012, 2:29-32.
39. Yum M.S., Ko T.S., Kim D.W. Beta-hydroxybutyrate increases the pilocarpine-induced seizure threshold in young mice. Brain Dev. 2012, 34:181-184.
40. Yum M.S., Lee M., Ko T.S., Velisek L. A potential effect of ganaxolone in an animal model of infantile spasms. Epilepsy Res. 2014, 108:1492-1500.